Karen Seibert, PhD

Washington University in St. Louis (WU)

My work is focused on identifying clinical and translational research programs designed to improve diagnosis or treatment of disease. I currently serve as Co-Director of the St Louis Center for Clinical Pharmacology, a newly formed joint research program between Washington University School of Medicine and the St Louis College of Pharmacy. The “Center for Clinical Pharmacology” primarily seeks the elucidation of novel uses of existing drugs and identification of new agents in the area of analgesia. Our approach focuses on the design and execution of clinical studies that utilize clinical biomarkers, assays and endpoints that translate basic science in pain research into clinical analgesia studies. Additionally, I am a member of the Senior Leadership Team of the Siteman Cancer Center, with oversight of the research cores that support both basic and clinical research studies, providing access to specialized technologies, services and expertise to investigators at Washington University and other partnered institutions.

Since being at Washington University I created the clinical genomics group known as “Genomics and Pathology Services”, a team of geneticists, molecular biologists, pathologists and bioinformaticians that developed specific clinical genomic tests in CAP/CLIA regulated laboratories for patient care and clinical research programs that span oncology, neurology and cardiology. Prior to joining Washington University School of Medicine in 2010, I spent twenty years in the pharmaceutical industry, most recently as the Head of R&D for Pfizer St Louis Laboratories, overseeing research and clinical development of new drug candidates across numerous therapeutic areas, including the marketed product, Celebrex.